X

ASCPT Journal Family

ASCPT Journal Family

ASCPT is proud to publish three peer-reviewed scientific research journals, spanning clinical pharmacology, pharmacometrics and systems pharmacology, and translational science. Submit your own research today!
*You are not currently logged in, please log in to access members-only journal content.

CPT December 2022

Clinical Pharmacology & Therapeutics

CPT is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to advances in the nature, action, efficacy, and evaluation of therapeutics.

Submit to CPT
PSP

CPT: Pharmacometrics & Systems Pharmacology

PSP is a timely online-only, cross-disciplinary journal publishing advances in quantitative methods as applied in pharmacology, physiology, and therapeutics in humans.

Submit to PSP

Clinical and Translational Science

CTS highlights original research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease.

Submit to CTS

  • Bonus Content
  • PSPost
  • Translational Bytes
  • Podcasts
  • Webinars
  • CPIC Guidelines
  • Editors-in-Training
The ASCPT Journal Family provides more than cutting-edge scientific content. The latest research, news, and views from clinical pharmacology, pharmacometrics and systems pharmacology, and translational science are put into perspective in our blogs, podcasts, and webinars.
All your ASCPT Journal Podcasts are available at one convenient site!
ClinPharmPod
     
PSPod
The following CPIC Guidelines have been endorsed by the ASCPT Board of Directors:
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2CP and Nonsteroidal Anti-Inflammatory Drugs

Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes

Clinical Pharmacogenetics Implementation Consortium (CPIC)Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update

Clinical Pharmacogenetics Implementation Consortium (CPIC)Guideline for CYP2D6 and Tamoxifen Therapy

Clinical Pharmacogenetics Implementation Consortium (CPIC)Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of Ondansetron and Tropisetron

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics- Guided Warfarin Dosing: 2017 Update


ASCPT Members can access published CPIC Guidelines in CPT.

The ASCPT Family of Journals cover a diverse range of topics within clinical pharmacology, translational science, pharmacometrics, and systems pharmacology. Each of the ASCPT journals will run independent consideration processes and select 1-2 Editors-in-Training.

The Editors-in-Training will be part of the core editorial teams and will be involved in the day-to-day manuscript consideration processes, including peer-review and decision-making, assist with strategic planning, and will be mentored by experienced members of the journals’ editorial teams. The role provides a unique training and personal development opportunity for outstanding early-career researchers to get closely involved in the running of a top peer-reviewed journal. At the same time, the editors-in-training will be responsible for helping the journals further their social media strategies as wells further develop the engagement of the ASCPT Early Career Community with the Family of Journals.

Main responsibilities
  • Support editorial team with manuscript review and decision making
  • Contribute to solicitation of high-quality manuscripts
  • Perform research and analysis to support the development of content and strategy (for example citation metrics, identification of key topics and authors, competitor analysis)
  • Work with ASCPT staff on the journals’ social media strategies and grow the online presence of the journals and their research
  • Act as the journals’ liaison with the ASCPT Early Career community
  • Take part in editorial team meetings
  • Provide feedback to editors-in-chief and other members of editorial team
  • When appropriate, communicate, present and publish findings to a wider ASCPT audience (ASCPT Newsletter, Webinar, Annual Meeting, CPT, Twitter AMA, open Q&A session)
  • Maintain confidentiality and fully adhere to the ASCPT and all journal policies and code of conduct
Terms and Conditions
  • Appointment is for up to an 18-month term
  • No compensation will be provided. Essential expenses will be reimbursed subject to ASCPT (pre)-approval.
  • Applicants may only apply to one of the journals and must identify their journal of choice in their submission cover letter.
To be considered for an Editor-in-Training position, please send your CV and a one-page letter of interest to Elise Laffman-Johnson at elise@ascpt.org by COB, Thursday, March 31, 2022. Applicants may only apply with one journal and must indicate their journal of choice in their cover letter. Interviews will be held with select applicants in mid-April, with exact dates to be determined by March 31, 2022, the final date for applications. Appointments will be confirmed for a May 16, 2022, start.
Photo Gallery
Recent News
Contact Us